- Symptomen > Vermoeidheid bij kanker in palliatieve f
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline

Laatst gewijzigd: 2019-05-09, Versie: 3.0, Verantwoording: IKNL, Type: Landelijke richtlijn


1 - NCCN (2017)

Cancer-related fatigue. Version 2. 2017- April 10, 2017. NCCN clinical practice guidelines in oncology. [link]

2 - IKNL Palliactief (2017)

IKNL/Palliactief 2017, Kwaliteitskader palliatieve zorg Nederland, 2017. [link]

3 - De Raaf PJ (2012)

de Raaf PJ, de Klerk C, Timman R, et al. Differences in fatigue experiences between advanced cancer patients, cancer survivors and the general population. J Pain Symptom Manage 2012, 44(6):823-830. [link]

4 - Hofman M (2007)

Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist 2007;12 Suppl 1:4-10. [link]

5 - Teunissen SC (2007)

Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34:94-104. [link]

6 - Jager A (2008)

Jager A, Sleijfer S, van der Rijt CC. The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer, 2008;44(2):175-181. [link]

7 - Koornstra RHT (2014)

Koornstra RHT, Peters M, Donofrio S, et al. Management of fatigue in patients with cancer a practical approach. Cancer Treatment Rev 2014; 40:791-799. [link]

8 - Radbruch L (2008)

Radbruch L, Strasser F, Elsner F, et al. Fatigue in palliative care patients - an EAPC approach. Palliat Med 2008;22:13-32. [link]

9 - Peters ME (2016)

Peters ME, Goedendorp MM, Verhagen CA, Bleijenberg G, van der Graaf WT. Fatigue and its associated psychosocial factors in cancer patients on active palliative treatment measured over time. Support Care Cancer, 2016; 24: 1349-1355. [link]

10 - Chang VT (2000)

Chang, Hwang SS, Feuermann M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000 May 1;88(9):2164-71. [link]

11 - Oldenmenger WH (2013)

Oldenmenger WH, De Raaf P, De Klerk C, et al. Cut points on 0-10 Numeric Rating Scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain Symptom Manage 2013;45:1083-1093. [link]

12 - Smets A (1995)

Smets A, Garssen B, Bonke B et al. The multidimensional fatique inventory (MFI) psychometric qualities of an instrument to assess fatique. J Psychosom Res,1995.39 (5): 315-325. [link]

13 - Worm-Smeitink M (2017)

Worm-Smeitink M, Gielissen M, Bloot L, et al The assessment of fatigue: psychometric qualities and norms for the Checklist Individual Strength. J Psychosom Res. 2017 Jul;98:40-6. [link]

14 - Bower JE (2014)

Bower JE. Cancer-related fatigue: mechanisms, risk factors and treatment. Nat Rev Clin Oncol. 2014; 11(10): 597-609. [link]

15 - Cheville (2010)

Cheville AL, Girardi J, Clark MM, et al. Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-being. Am J Phys Med Rehabil. 2010;89(8):611-9. [link]

16 - Bennett S (2016)

Bennett S, Pigott A, Beller EM,et al. Educational interventions for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2016;11:Cd008144. [link]

17 - Bruera E (2013)

Bruera E, Yennurajalingam S, Palmer JL, et al. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol: official journal of the American Society of Clinical Oncology. 2013;31(19):2421-7. [link]

18 - Bordeleau L (2003)

Bordeleau L, Szalai JP, Ennis M, et al. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol. 2003;21:1944-51. [link]

20 - Chan CW (2011)

Chan CW, Richardson A, Richardson J. Managing symptoms in patients with advanced lung cancer during radiotherapy: results of a psychoeducational randomized controlled trial. J Pain Symptom Manage. 2011;41(2):347-57. [link]

21 - Classen C (2001)

Classen C, Butler LD, Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Archives of General Psychiatry 2001;58:494-501. [link]

22 - Poort H (2017)

Poort H, Peters M, Bleijenberg G, et al. Psychosocial interventions for fatigue during cancer treatment with palliative intent. Cochrane Database Syst Rev. 2017;7:CD012030. [link]

23 - Steel JL (2016)

Steel JL, Geller DA, Kim KH, et al. Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer 2016;122(8):1270-82. [link]

24 - Eizenga WH (2006)

Eizenga WH, De Bont M, Vriezen JA, et al. METC. Landelijke eerstelijns samenwerkingsafspraak palliatieve zorg. Huisarts en Wetenschap 2006; 49: 308-312. [link]

25 - Bohlius J (2009)

Bohlius J, Schmidlin K, Brillant C et al. Recombinant human erythopoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009; 373: 1532-1542. [link]

26 - De Raaf PJ (2013)

De Raaf PJ, de Klerk C, Timman R, et al: Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial. J Clin Oncol 2013; (31:716-23. [link]

28 - Rizzo JD (2007)

Rizzo JD, Somerfield MR, Hagerty KL et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 2008; 26: 132-149. [link]

29 - Sharpe M (2014)

Sharpe M. Walker J, Holm Hansen C, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet 2014; 384(9948):1099-1108. [link]

30 - To THM (2017)

To THM, LeBlanc TW, Eastman P et al. The prospective evaluation of the net effect of red blood cell transfusion in routine provision of palliative care. J Pall Med 2017; 20: 1152-7. [link]

31 - Wilson J (2007)

Wilson J, Yao GL, Raftery J, et al. A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess 2007; 11: 1-221. [link]

32 - Armes J (2007)

Armes J, Chalder T, Addington-Hall J, Richardson A, Hotopf M. A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer 2007;110(6):1385-95. [link]

33 - Barsevick AM (2004)

Barsevick AM, Dudley W, Beck S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 2004:100 (6):1302-10. [link]

34 - Barsevick A (2010)

Barsevick A, Beck SL, Dudley WN, Wong B, Berger AM, Whitmer K, et al. Ef?cacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage 2010;40(2):200-16. [link]

40 - Edelman S (1999)

Edelman S, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-oncology 1999;8(4):295-305. [link]

41 - Johansson B (2008)

Johansson B, Brandberg Y, Hellbom M, Persson C, Petersson LM, Berglund G, et al. Health-related quality of life and distress in cancer patients: results from a large randomised study. BJC. 2008;99(12): 1975-83. [link]

42 - Savard J (2006)

Savard J, Simard S, Giguère I, Ivers H, Morin CM, Maunsell E, et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 2006;4(3):219-37. [link]

44 - Spiegel D (1981)

Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981;38(5):527-33. [link]

46 - Walker J (2014)

Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncology 2014;15(10): 1168-76. [link]

47 - Adamsen L (2009)

Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009;339:b3410 [link]

48 - Albrecht TA (2012)

Albrecht TA, Taylor AG. Physical activity in patients with advanced-stage cancer: a systematic review of the literature. Clin J Oncol Nurs. 2012;16(3):293-300. [link]

49 - Beaton R (2009)

Beaton R, Pagdin-Friesen W, Robertson C, et al. Effects of exercise intervention on persons with metastatic cancer: a systematic review. Physiother Can. 2009;61(3):141-53. [link]

50 - Bourke L (2014)

Bourke L, Gilbert S, Hooper R, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol. 2014;65(5):865-72. [link]

51 - Brown P (2006)

Brown P, Clark MM, Atherton P, et al., 2006. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer? Am. J. Clin. Oncol. 2006;29, 52-58. [link]

52 - Cheville AL (2013)

Cheville AL, Kollasch J, Vandenberg J, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage. 2013;45(5):811-21. [link]

53 - Cormie P (2013)

Cormie P, Newton RU, Spry N,et al. Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate cancer and prostatic diseases. 2013;16(4):328-35. [link]

54 - Cramp F (2012)

Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults (Review). Cochrane Database Syst Rev 2012;Nov 14 (11).: CD006145. [link]

55 - Dhillon HM (2017)

Dhillon HM, Bell ML, van der Ploeg HP, et al. Impact of Physical Activity on Fatigue and Quality of Life in People with Advanced Lung Cancer: a Randomised Controlled Trial. Annals of oncology : official journal of the European Society for Medical Oncology. 2017. [link]

56 - Dittus KL (2017)

Dittus KL, Gramling RE, Ades PA. Exercise interventions for individuals with advanced cancer: A systematic review. Prev Med. 2017;104:124-132. [link]

57 - Headly JA (2004)

Headly JA, Ownby KK, John LD. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum. 2004;31(5):977-983. [link]

58 - Henke CC (2014)

Henke CC, Cabri J, Fricke L, et al. Strength and endurance training in the treatment of lung cancer patients in stages IIIA/IIIB/IV. Support Care Cancer 2014;22:95-101. [link]

59 - Hwang CL (2012)

Hwang CL, Yu CJ, Shih JY, Yang, PC, Wu YT. Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy. Support Care Cancer 2012;20:3169-3177. [link]

60 - Jensen W (2014)

Jensen W, Baumann FT, Stein A, et al. Exercise training in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2014;22(7):1797-806. [link]

61 - Ligibel JA (2016)

Ligibel JA, Giobbie-Hurder A, Shockro L, et al. Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer. 2016;122(8):1169-77. [link]

62 - Litterini AJ (2013)

Litterini AJ, Fieler VK, Cavanaugh JT,et al. Differential effects of cardiovascular and resistance exercise on functional mobility in individuals with advanced cancer: a randomized trial. Archives of physical medicine and rehabilitation. 2013;94(12):2329-35. [link]

63 - Lopez-Sendin N (2012)

Lopez-Sendin N, Alburquerque-Sendin F, Cleland JA, et al. Effects of physical therapy on pain and mood in patients with terminal cancer: a pilot randomized clinical trial. J Altern Complement Med (New York, NY). 2012;18(5):480-6. [link]

64 - Lowe SS (2009)

Lowe SS, Watanabe SM, Courneya KS. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J. Support Oncol. 2009;7(1):27-34. [link]

65 - Mayo NE (2014)

Mayo NE, Moriello C, Scott SC, et al. Pedometer-facilitated walking intervention shows promising effectiveness for reducing cancer fatigue: a pilot randomized trial. Clin Rehabil. 2014;28(12):1198-209. [link]

66 - Mishra SI (2012)

Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012, Aug 15 (8): CD008465. [link]

67 - Oldervoll LM (2011)

Oldervoll LM, Loge JH, Lydersen S, et al. Physical exercise for cancer patients with advanced disease: a randomized controlled trial. The oncologist. 2011;16(11):1649-57. [link]

68 - Pyszora A (2017)

Pyszora A, Budzynski J, Wojcik A, et al. Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: randomized controlled trial. Supportive care in cancer : Support Care Cancer. 2017;25(9):2899-908. [link]

69 - Rief H (2014)

Rief H, Akbar M, Keller M, et al. Quality of life and fatigue of patients with spinal bone metastases under combined treatment with resistance training and radiation therapy- a randomized pilot trial. Radiat Oncol Investig. 2014;9:151. [link]

70 - Salakari MR (2015)

Salakari MR, Surakka T, Nurminen R, et al. Effects of rehabilitation among patients with advances cancer: a systematic review. Acta Oncol. 2015;54(5):618-28. [link]

71 - Schmitz KH (2010)

Schmitz KH, Courneya KS, Matthews C et al. American College of Sports Medicine roundtable on exercise 1662 guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409-26. [link]

72 - Schuler MK (2017)

Schuler MK, Hentschel L, Kisel W, et al. 017. Impact of different exercise programs on severe fatigue in patients undergoing anticancer treatment - a randomized controlled trial. J Pain Symptom Manag. 2017;53:57-66. [link]

73 - Tsianakas V (2017)

Tsianakas V, Harris J, Ream E, et al. CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer. BMJ Open 2017;7(2):e013719. [link]

74 - Uster A (2017)

Uster A, Ruehlin M, Mey S, et al. Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial. Clin Nutr. 2017. [link]

75 - Vanderbyl B (2017)

Vanderbyl B, Mayer M, Nash C, et al. A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer. Support Care Cancer. 2017;25(6):1749-58. [link]

76 - Bruera E (1985)

Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treatment Reports 1985; 69: 751-4. [link]

77 - Chow E (2015)

Chow E, Meyer RM, Ding K, et al.Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. 2015 Nov;16(15):1463-72. [link]

78 - Della Cuna GR (1989)

Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol. 1989;25(12):1817-21 [link]

79 - Eguchi K (2015)

Eguchi K, Honda M, Kataoka T, et al. Efficacy of corticosteroids for cancer-related fatigue: A pilot randomized placebo-controlled trial of advanced cancer patients. Palliat Support Care. 2015;13(5):1301-8. [link]

80 - Mercadante SL (2007)

Mercadante SL, Berchovich M, Casuccio A, et al. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care. 2007;24(1):13-9. [link]

81 - Minton O (2010)

Minton O, Richardson A, Sharpe M, et al. Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev. 2010(7):Cd006704. [link]

82 - Mucke M (2015)

Mucke M, Cuhls H, Peuckmann-Post V, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2015(5):Cd006788. [link]

83 - Peuckmann V (2010)

Peuckmann V, Elsner F, Krumm N, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010(11):Cd006788. [link]

84 - Paulsen O (2014)

Paulsen O, Klepstad P, Rosland JH, et al. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. Journal of clinical oncology : J Clin Oncol. 2014;32(29):3221-8. [link]

85 - Yennurajalingam S (2013)

Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of clinical oncology : J Clin Oncol. 2013;31(25):3076-82. [link]

86 - Auret KA (2009)

Auret KA, Schug SA, Bremner AP,et al. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manage. 2009;37(4):613-21. [link]

87 - Bruera E (2006)

Bruera E, Valero V, Driver L et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24(13):2073-8. [link]

89 - Butler JM Jr (2007)

Butler JM Jr, Case LD, Atkins J0 et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69(5):1496-501. [link]

93 - Escalante CP (2014)

Escalante CP, Meyers C, Reuben JM et al. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014;20(1):8-14. [link]

94 - Hovey E (2014)

Hovey E, de Souza P, Marx G, et al. Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Support Care Cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2014;22(5):1233-42. [link]

95 - Jean-Pierre P (2010)

Jean-Pierre P, Morrow GR, Roscoe JA et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 2010;116(14):3513-20. [link]

96 - Kerr CW (2012)

Kerr CW, Drake J, Milch RA et al. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 2012;43(1):68-77. [link]

97 - Lundorff LE (2009)

Lundorff LE, Jonsson BH, Sjogren P. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliat Med. 2009;23(8):731-8. [link]

99 - Moraska AR (2010)

Moraska AR, Sood A, Dakhil SR, et al. Phase III, randomized, double-blind, placebo-controlled study of long-actng methylphenidate for cancer-relared fatigue: North Central Cancer treatment Group NCCTG-N-5C7 Trial. J Clin Oncol 2010; 28(23):3673-3679. [link]

101 - Roth AJ (2010)

Roth AJ, Nelson C, Rosenfeld B, et al. Methylphenidate for fatigue in ambulatory men with prostate cancer. Cancer. 2010;116(21):5102-10. [link]

102 - Spathis A (2014)

Spathis A, Fife K, Blackhall F, et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol. 2014;32(18):1882-8. [link]

105 - Morrow GR1 (2003)

Morrow GR1, Hickok JT, Roscoe JA et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin. Oncol. 2003;21(24): 463541. [link]

106 - Lacasse Y1 (2004)

Lacasse Y1, Beaudoin L, Rousseau L et al. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61(3):140-7. [link]

107 - Stockler MR (2007)

Stockler MR, O'Connell R, Nowak AK, et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. The Lancet Oncology. 2007;8(7):603-12. [link]